X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/halozyme-to-present-at-upcoming-investor-conferences-301914448.html
https://www.reuters.com/world/uk/england-rollout-world-first-seven-minute-cancer-treatment-jab-2023-08-29/
https://www.prnewswire.com/news-releases/halozyme-announces-approval-of-roches-tecentriq-subcutaneous-sc-with-enhanze-in-great-britain-301911904.html
https://www.prnewswire.com/news-releases/halozyme-reports-second-quarter-2023-financial-and-operating-results-301896108.html
https://www.prnewswire.com/news-releases/halozyme-to-report-second-quarter-2023-financial-and-operating-results-301884812.html
https://finance.yahoo.com/news/halozyme-therapeutics-halo-soars-5-093900421.html
https://ir.halozyme.com/news/news-details/2023/Positive-Topline-Data-Reported-from-argenxs-ADHERE-Study-of-VYVGART-Hytrulo-with-Halozymes-ENHANZE-Drug-Delivery-Technology-in-Patients-with-Chronic-Inflammatory-Demyelinating-Polyneuropathy/default.aspx
https://www.fiercepharma.com/pharma/roches-new-subcutaneous-version-measures-iv-ocrevus
https://www.prnewswire.com/news-releases/halozyme-announces-argenx-receives-fda-approval-for-vyvgart-hytrulo-with-enhanze-for-subcutaneous-use-in-generalized-myasthenia-gravis-301855994.html
https://www.prnewswire.com/news-releases/halozyme-to-present-at-the-goldman-sachs-44th-annual-global-healthcare-conference-301843265.html
Market Place
Share 
